KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Cash & Equivalents (2016 - 2026)

Fulgent Genetics' Cash & Equivalents history spans 12 years, with the latest figure at $23.4 million for Q1 2026.

  • On a quarterly basis, Cash & Equivalents fell 65.22% to $23.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $23.4 million, a 65.22% decrease, with the full-year FY2025 number at $50.2 million, down 8.98% from a year prior.
  • Cash & Equivalents hit $23.4 million in Q1 2026 for Fulgent Genetics, down from $50.2 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for FLGT hit a ceiling of $353.1 million in Q1 2022 and a floor of $23.4 million in Q1 2026.
  • Historically, Cash & Equivalents has averaged $84.3 million across 5 years, with a median of $66.2 million in 2023.
  • Biggest five-year swings in Cash & Equivalents: soared 703.65% in 2022 and later crashed 81.26% in 2023.
  • Tracing FLGT's Cash & Equivalents over 5 years: stood at $79.5 million in 2022, then increased by 22.6% to $97.5 million in 2023, then tumbled by 43.43% to $55.1 million in 2024, then fell by 8.98% to $50.2 million in 2025, then crashed by 53.38% to $23.4 million in 2026.
  • Business Quant data shows Cash & Equivalents for FLGT at $23.4 million in Q1 2026, $50.2 million in Q4 2025, and $117.6 million in Q3 2025.